EUVIMEDEUVIMED entdecken
Crossref

Reprogrammed Lung Metastasis Immunodeficiency via Targeted Penetrated Delivery of M1 Macrophage‐Wrapped NanoCubes‐Mediated T Cell Infiltration

Kang-Li Wang iD, Cheng-Han Li, Pin-Xuan Huang, Hsiu-Ching Liu, Bhanu Nirosha Yalamandala iD, Wan-Chi Pan, Hoi Man Iao, Shang-Hsiu Hu iD

Small · 2025-01 · 21 (3)

DOI: 10.1002/smll.202406790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 22.11.2024. Verfasst von Kang-Li Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, 300044, Taiwan. Hauptthemen laut MEDLINE: Lung Neoplasms, Macrophages, T-Lymphocytes, Nanoparticles. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Science and Technology Council, National Tsing Hua University, National Health Research Institutes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The infiltration of cytotoxic T lymphocytes holds promise for suppressing even the most resilient metastatic tumors in immunotherapy. Polarizing tumor‐associated macrophages (TAMs) and remodeling the immune‐deficient tumor microenvironment (TME) can enhance T lymphocyte recruitment and infiltration. However, the immune privilege and low immunogenic responses of these aggressive tumor clusters often limit lymphocyte recruitment. Here, an M1 macrophage membrane‐coated iron oxide nanoparticle (IO@MM) double as a tumor‐penetrated agent and naïve M0 macrophage to M1 polarizer is developed for lung metastatic colorectal cancer (CRC) immunotherapy. At the tumor site, IO@MM combined with resiquimod (R848) increased the immune cell infiltration, turning the “Cold” TME into an immune‐activating “Hot” one. Together with self‐cascade immunotherapy, IO@MM with R848 promotes tumor release of damage‐associated molecular patterns (DAMPs). At the same time, IO@MM uses the membrane as an antigen reservoir and provides autologous DAMPs to retain dendritic cells. This IO@MM effectively inhibits tumors and improves survival rate as an immunomodulator in lung metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMacrophagesT-LymphocytesNanoparticlesAnimalsMiceTumor MicroenvironmentImmunotherapyMice, Inbred C57BLCell Line, TumorHumansImidazoles

Stichwörter der Autor:innen

immunotherapymacrophage membrane‐coated nanoparticlemetastatic colorectal cancertumor microenvironment

Substanzen

resiquimodImidazoles

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, 300044, Taiwan.

ORCID-Profile: Kang-Li Wang, Bhanu Nirosha Yalamandala, Shang-Hsiu Hu

Förderung

  • National Science and Technology Council
  • National Tsing Hua University
  • National Health Research Institutes

Zitieren

APA

Wang, K. L., Li, C. H., Huang, P. X., Liu, H. C., Yalamandala, B. N., Pan, W. C., Iao, H. M., & Hu, S. H. (2025). Reprogrammed Lung Metastasis Immunodeficiency via Targeted Penetrated Delivery of M1 Macrophage‐Wrapped NanoCubes‐Mediated T Cell Infiltration. Small, 21(3). https://doi.org/10.1002/smll.202406790

Vancouver

Wang KL, Li CH, Huang PX, Liu HC, Yalamandala BN, Pan WC, et al. Reprogrammed Lung Metastasis Immunodeficiency via Targeted Penetrated Delivery of M1 Macrophage‐Wrapped NanoCubes‐Mediated T Cell Infiltration. Small. 2025;21(3). doi:10.1002/smll.202406790

BibTeX
@article{Wang2025,
  author = {Wang, Kang-Li and Li, Cheng-Han and Huang, Pin-Xuan and Liu, Hsiu-Ching and Yalamandala, Bhanu Nirosha and Pan, Wan-Chi and Iao, Hoi Man and Hu, Shang-Hsiu},
  title = {Reprogrammed Lung Metastasis Immunodeficiency via Targeted Penetrated Delivery of M1 Macrophage‐Wrapped NanoCubes‐Mediated T Cell Infiltration},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {3},
  doi = {10.1002/smll.202406790}
}
Kostenlos starten →